Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation
- 15 June 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (12), 1558-1560
- https://doi.org/10.1016/j.amjcard.2004.02.071
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparison of Plasma Concentrations for Two Amiodarone ProductsAnnals of Pharmacotherapy, 2002
- Substitution of Generic Warfarin for Coumadin in an HMO SettingAnnals of Pharmacotherapy, 2002
- A retrospective assessment of safety, efficacy, and pharmacoeconomics of generic azathioprine in heart-transplant recipientsThe Journal of Heart and Lung Transplantation, 2001
- Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmiasThe American Journal of Cardiology, 2000
- Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practiceThe American Journal of Cardiology, 2000
- Israel introduces generic drugs schemeBMJ, 1999